Catalyst Wire Dossier Catalyst Wire Dossier

Nesiritide

recombinant human B-type natriuretic peptide (rhBNP) · Scios, Inc.
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Nesiritide, covering 2008-07-03 to 2025-07-29. Get the full timeline:

Most recent: Clinical Trial Update: Recombinant Human Brain Natriuretic Peptide for the Recovery Stage of Septic Shock [NA]

See pricing